Topic

biotech

€1.3M Pre-seed Funding for Lucid Genomics to Fine-tune Their AI Models for Diagnostics and Biomarker Discovery

Insider Brief Lucid Genomics, a spin-off from the Max Planck Institute, raised €1.3 million in pre-seed funding to advance its AI-driven genomic analysis platform, VisionSort™, focusing on the complete analysis of the genome. The

2 Sep 2024 · 5 min read

Technology & Infrastructure · Applications & agents

Inceptive Pioneers AI-Driven Therapeutic Molecule Design

16 Jul 2024

Business & Markets · Startups

Ability Biologics Announces the Closing of its US $18M Seed Funding Extension Toward the Generation of Novel, Highly Targeted Immunomodulators

18 Jun 2024

Business & Markets · Startups

Enveda Biosciences Announces $55M in New Funding to Accelerate Platform and Advance Multiple Candidates to Clinical Trials

16 Jun 2024

Business & Markets · Startups

Reshape Raises $20M Series A to Scale AI-Powered Imaging and Analysis Platform for Biotech, Agriculture, and Food R&D

15 Apr 2024

Business & Markets · Startups

QuantHealth Secures Funding from Accenture and Other Investors to Deliver AI-powered Clinical Trial Simulations for Pharmaceutical and Biotech Companies

10 Jan 2024

Business & Markets · Startups

Unnatural Products, Inc. Announces $32 Million in Series A Funding to Pair AI And Chemistry to Target Therapeutics

29 Dec 2023

biotech

€1.3M Pre-seed Funding for Lucid Genomics to Fine-tune Their AI Models for Diagnostics and Biomarker Discovery

Inceptive Pioneers AI-Driven Therapeutic Molecule Design

Ability Biologics Announces the Closing of its US $18M Seed Funding Extension Toward the Generation of Novel, Highly Targeted Immunomodulators

Enveda Biosciences Announces $55M in New Funding to Accelerate Platform and Advance Multiple Candidates to Clinical Trials

Reshape Raises $20M Series A to Scale AI-Powered Imaging and Analysis Platform for Biotech, Agriculture, and Food R&D

QuantHealth Secures Funding from Accenture and Other Investors to Deliver AI-powered Clinical Trial Simulations for Pharmaceutical and Biotech Companies

Unnatural Products, Inc. Announces $32 Million in Series A Funding to Pair AI And Chemistry to Target Therapeutics

Trending today

Outmarket AI Raises $34.5M Series B to Solidify Position as the #1 AI Platform for Insurance

Meta’s Muse AI Agent Tops 3.4M Downloads as Meta Opens Early Access to New Features

China’s MirrorMe Unveils Viva Dexterous Hand that Performs Human-Robot Piano Duet

10 Switzerland-Based AI Scale-Ups You Need to Know in 2026

Nscale Secures $3.36B in Convertible Financing Ahead of NYSE IPO

biotech

€1.3M Pre-seed Funding for Lucid Genomics to Fine-tune Their AI Models for Diagnostics and Biomarker Discovery

Inceptive Pioneers AI-Driven Therapeutic Molecule Design

Ability Biologics Announces the Closing of its US $18M Seed Funding Extension Toward the Generation of Novel, Highly Targeted Immunomodulators

Enveda Biosciences Announces $55M in New Funding to Accelerate Platform and Advance Multiple Candidates to Clinical Trials

Reshape Raises $20M Series A to Scale AI-Powered Imaging and Analysis Platform for Biotech, Agriculture, and Food R&D

QuantHealth Secures Funding from Accenture and Other Investors to Deliver AI-powered Clinical Trial Simulations for Pharmaceutical and Biotech Companies

Unnatural Products, Inc. Announces $32 Million in Series A Funding to Pair AI And Chemistry to Target Therapeutics

Trending today

Outmarket AI Raises $34.5M Series B to Solidify Position as the #1 AI Platform for Insurance

Meta’s Muse AI Agent Tops 3.4M Downloads as Meta Opens Early Access to New Features

China’s MirrorMe Unveils Viva Dexterous Hand that Performs Human-Robot Piano Duet

10 Switzerland-Based AI Scale-Ups You Need to Know in 2026

Nscale Secures $3.36B in Convertible Financing Ahead of NYSE IPO

The AI economy, every weekday morning